Blood Group Typing Market Updates

Global Blood Group Typing Market size was valued at USD 1.89 Billion in 2023 and is poised to grow from USD 2.08 Billion in 2024 to USD 4.18 Billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

Blood group typing providers should focus on raising more awareness regarding the importance of blood donations and transfusions to maximize their sales potential. Investing in the R&D of novel portable and rapid blood typing solutions is also a key opportunity for companies as per this global blood group typing market analysis. 'Quotient Limited (Switzerland)', 'CareDx Inc. (U.S.)', 'Agena Bioscience, Inc. (Mesa Laboratories, Inc.) (U.S.)', 'DIAGAST (U.S.)', 'Illumina, Inc. (U.S.)', 'Grifols, S.A. (Spain)', 'Immucor, Inc. (U.S.)', 'Bio-Rad Laboratories, Inc. (U.S.)', 'Thermo Fisher Scientific Inc. (U.S.)', 'Merck KGaA (Germany)', 'QIAGEN (Netherlands)', 'Beckman Coulter, Inc. (Danaher) (U.S.)', 'QuidelOrtho Corporation (U.S.)'

Governments around the world are implementing policies and programs to promote blood donation and ensure the safety of blood transfusions. These initiatives significantly boost blood group typing market outlook by increasing awareness and accessibility of blood typing services. Public health campaigns and subsidies for blood typing equipment are supporting healthcare facilities in adopting advanced blood typing technologies going forward.

Shift Toward Molecular Blood Typing Techniques: Shift from traditional serological methods to advanced molecular typing techniques is gaining traction around the world. Molecular methods, such as PCR and DNA sequencing, allow for more precise identification of rare and weak blood group antigens. These technologies are especially beneficial in complex cases, such as prenatal testing and multi-transfused patients. They also reduce the risk of alloimmunization and transfusion reactions. Hence, focusing on this blood group typing industry trend is slated to help boost revenue generation potential across the study period.

Why is the Adoption of Blood Group Typing High in North America?